Bill Miller
Miller Value Partners
Bill Miller Medical Properties Trust, Inc stake
total: 463
Miller Value Partners MPT trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 2
- Held since:
- 2022 Q3
- Held for:
- 6 quarters
- Latest activity:
- 2024 Q1
According to 2026 Q2 report, Bill Miller doesn't hold any Medical Properties Trust, Inc (MPT) shares. To date, the estimated cost basis is nearly $8.92 for "buy" trades and estimated average "sell" price is $5.05. Miller Value Partners first purchased MPT in 2022 Q3, initially acquiring 332,000 shares. Since the initial investment in Medical Properties Trust, Inc (MPT), Miller Value Partners has made 6 more transactions.
When did Bill Miller sell Medical Properties Trust, Inc (MPT)?
Bill Miller sold off the entire Medical Properties Trust, Inc (MPT) position in 2024 Q1.
When did Bill Miller buy Medical Properties Trust, Inc (MPT)?
Bill Miller first invested in Medical Properties Trust, Inc (MPT) in 2022 Q3 at the reported quarter-end price of $11.86 per share.
What's the cost basis of Miller Value Partners's MPT stake?
The estimated cost basis for Medical Properties Trust, Inc (MPT) stake is around $8.92 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $8.92
- Weighted AVG sell price:
- $5.05
Bill Miller's historical trades in Medical Properties Trust, Inc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q1
|
0.00%
|
0
|
$4.91
|
|
-100% (-991,000)
|
-2.89%
|
|
2023 Q4
|
2.89%
|
991,000
|
$4.91
|
$4,865,810
|
+58.31% (+365,000)
|
+1.06%
|
|
2023 Q3
|
2.14%
|
626,000
|
$5.45
|
$3,411,700
|
-4.57% (-30,000)
|
-0.11%
|
|
2023 Q2
|
4.00%
|
656,000
|
$9.26
|
$6,074,560
|
-4.51% (-31,000)
|
-0.02%
|
|
2023 Q1
|
0.35%
|
687,000
|
$8.22
|
$5,647,140
|
+18.04% (+105,000)
|
+0.05%
|
|
2022 Q4
|
0.42%
|
582,000
|
$11.14
|
$6,483,480
|
+75.30% (+250,000)
|
+0.18%
|
|
2022 Q3
|
0.24%
|
332,000
|
$11.86
|
$3,938,000
|
new
|
+0.24%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.